{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T05:33:43Z","timestamp":1740807223532,"version":"3.38.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004329","name":"Javna Agencija za Raziskovalno Dejavnost RS","doi-asserted-by":"publisher","award":["P3-0326"],"award-info":[{"award-number":["P3-0326"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Titin truncating variants (<jats:italic>TTN<\/jats:italic>tv-s) are the most common genetic cause of dilated cardiomyopathy (DCM). Only rare <jats:italic>TTN<\/jats:italic>tv-s in the constitutively expressed exons of the A-band of the protein titin are associated with DCM according to the guidelines, however, studies in large cohorts of patients with DCM suggest that the region where <jats:italic>TTN<\/jats:italic>tv-s are associated with DCM is wider, extending at least into the I-band. The aim of this study was to describe the molecular pathology of <jats:italic>TTN<\/jats:italic>tv-s in Slovenian patients with cardiomyopathy and to clinically characterise the most recurrent <jats:italic>TTN<\/jats:italic>tv.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>We collected all <jats:italic>TTN<\/jats:italic>tv-s identified in patients with cardiomyopathy using next-generation sequencing genetic testing between 2010 and July 2024, resulting in 42 unique variants identified in 54 patients. The <jats:italic>TTN<\/jats:italic>:c.12478del variant, affecting not the A-band but the proximal I-band, specifically the cardiac-specific N2Bus region, was found to be the most recurrent variant, present in seven (11.6%) probands with DCM. Genetic characterisation revealed a probable founder origin of the variant. Clinical characterisation of these probands revealed a phenotype consistent with DCM and severely reduced left ventricular ejection fraction in all probands. Three (43%) of the probands had atrial fibrillation and\/or non-sustained ventricular tachycardia. Based on literature reports and evidence supporting the pathogenicity of the <jats:italic>TTN<\/jats:italic>:c.12478del variant affecting the proximal I-band, we classified all rare <jats:italic>TTN<\/jats:italic>tv-s in constitutively expressed exons of the I-band as (likely) pathogenic. Therefore, 33 (78.6%) <jats:italic>TTN<\/jats:italic>tv-s were classified as (likely) pathogenic (13 in the I-band, affecting 19 probands and 20 in the A-band affecting 25 probands), meaning that <jats:italic>TTN<\/jats:italic>tv-s were identified in 44 genotype-positive Slovenian probands with DCM, explaining 73.3% of the molecular pathology of DCM.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>We report an almost threefold higher diagnostic yield of <jats:italic>TTN<\/jats:italic>tv-s in probands with DCM compared to previously reported findings in cohorts of patients with DCM from other populations. We also highlight the need for screening for rare <jats:italic>TTN<\/jats:italic>tv-s in the constitutively expressed exons of the I-band and for <jats:italic>TTN<\/jats:italic>:c.12478del in patients with DCM in this geographical region.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13023-025-03613-7","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T13:15:18Z","timestamp":1740748518000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["TTN:c.12478del in proximal I-band of titin represents a common molecular cause of dilated cardiomyopathy in Slovenian patients"],"prefix":"10.1186","volume":"20","author":[{"given":"Nina","family":"Vodnjov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andra\u017e","family":"Cerar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ale\u0161","family":"Maver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Borut","family":"Peterlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0388-5361","authenticated-orcid":false,"given":"Karin","family":"Writzl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,28]]},"reference":[{"key":"3613_CR1","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1002\/joa3.12717","volume":"38","author":"AAM Wilde","year":"2022","unstructured":"Wilde AAM, Semsarian C, M\u00e1rquez MF, Sepehri Shamloo A, Ackerman MJ, Ashley EA, et al. European heart rhythm association (EHRA)\/Heart rhythm society (HRS)\/Asia Pacific heart rhythm society (APHRS)\/Latin American heart rhythm society (LAHRS) expert consensus statement on the state of genetic testing for cardiac diseases. J Arrhythmia. 2022;38:491\u2013553.","journal-title":"J Arrhythmia"},{"key":"3613_CR2","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s00059-019-4825-4","volume":"45","author":"H-J Fang","year":"2020","unstructured":"Fang H-J, Liu B-P. Prevalence of TTN mutations in patients with dilated cardiomyopathy: A meta-analysis. Herz. 2020;45:29\u201336.","journal-title":"Herz"},{"key":"3613_CR3","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1002\/humu.24309","volume":"43","author":"S Gudmundsson","year":"2022","unstructured":"Gudmundsson S, Singer-Berk M, Watts NA, Phu W, Goodrich JK, Solomonson M, et al. Variant interpretation using population databases: lessons from GnomAD. Hum Mutat. 2022;43:1012\u201330.","journal-title":"Hum Mutat"},{"key":"3613_CR4","doi-asserted-by":"crossref","unstructured":"Akinrinade O, Koskenvuo JW, Alastalo T-P. Prevalence of titin truncating variants in general population. Krahe R, editor. PLoS ONE. 2015;10:e0145284.","DOI":"10.1371\/journal.pone.0145284"},{"key":"3613_CR5","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/S0006-3495(95)80278-X","volume":"68","author":"HL Granzier","year":"1995","unstructured":"Granzier HL, Irving TC. Passive tension in cardiac muscle: contribution of collagen, titin, microtubules, and intermediate filaments. Biophys J. 1995;68:1027\u201344.","journal-title":"Biophys J"},{"key":"3613_CR6","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1126\/science.270.5234.293","volume":"270","author":"S Labeit","year":"1995","unstructured":"Labeit S, Kolmerer B. Titins: giant proteins in charge of muscle ultrastructure and elasticity. Science. 1995;270:293\u20136.","journal-title":"Science"},{"key":"3613_CR7","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1161\/hh2301.100981","volume":"89","author":"ML Bang","year":"2001","unstructured":"Bang ML, Centner T, Fornoff F, Geach AJ, Gotthardt M, McNabb M, et al. The complete gene sequence of titin, expression of an unusual approximately 700-kDa titin isoform, and its interaction with obscurin identify a novel Z-line to I-band linking system. Circ Res. 2001;89:1065\u201372.","journal-title":"Circ Res"},{"key":"3613_CR8","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/ng.3719","volume":"49","author":"S Schafer","year":"2017","unstructured":"Schafer S, De Marvao A, Adami E, Fiedler LR, Ng B, Khin E, et al. Titin-truncating variants affect heart function in disease cohorts and the general population. Nat Genet. 2017;49:46\u201353.","journal-title":"Nat Genet"},{"key":"3613_CR9","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1083\/jcb.146.3.631","volume":"146","author":"WA Linke","year":"1999","unstructured":"Linke WA, Rudy DE, Centner T, Gautel M, Witt C, Labeit S, et al. I-band titin in cardiac muscle is a three-element molecular spring and is critical for maintaining thin filament structure. J Cell Biol. 1999;146:631\u201344.","journal-title":"J Cell Biol"},{"key":"3613_CR10","doi-asserted-by":"publisher","first-page":"4496","DOI":"10.1038\/s41467-024-48828-7","volume":"15","author":"Y Sun","year":"2024","unstructured":"Sun Y, Liu X, Huang W, Le S, Yan J. Structural domain in the titin N2B-us region binds to FHL2 in a force-activation dependent manner. Nat Commun. 2024;15:4496.","journal-title":"Nat Commun"},{"key":"3613_CR11","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s12551-021-00836-3","volume":"13","author":"RJ van der Pijl","year":"2021","unstructured":"van der Pijl RJ, Domenighetti AA, Sheikh F, Ehler E, Ottenheijm CAC, Lange S. The titin N2B and N2A regions: biomechanical and metabolic signaling hubs in cross-striated muscles. Biophys Rev. 2021;13:653\u201377.","journal-title":"Biophys Rev"},{"key":"3613_CR12","doi-asserted-by":"publisher","first-page":"eabd3079","DOI":"10.1126\/scitranslmed.abd3079","volume":"13","author":"A Fomin","year":"2021","unstructured":"Fomin A, G\u00e4rtner A, Cyganek L, Tiburcy M, Tuleta I, Wellers L, et al. Truncated titin proteins and titin haploinsufficiency are targets for functional recovery in human cardiomyopathy due to TTN mutations. Sci Transl Med. 2021;13:eabd3079.","journal-title":"Sci Transl Med"},{"key":"3613_CR13","doi-asserted-by":"publisher","first-page":"e006832","DOI":"10.1161\/CIRCHEARTFAILURE.119.006832","volume":"13","author":"MM Akhtar","year":"2020","unstructured":"Akhtar MM, Lorenzini M, Cicerchia M, Ochoa JP, Hey TM, Sabater Molina M, et al. Clinical phenotypes and prognosis of dilated cardiomyopathy caused by truncating variants in the TTN gene. Circ Heart Fail. 2020;13:e006832.","journal-title":"Circ Heart Fail"},{"key":"3613_CR14","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/cge.12741","volume":"90","author":"O Akinrinade","year":"2016","unstructured":"Akinrinade O, Alastalo T-P, Koskenvuo JW. Relevance of truncating titin mutations in dilated cardiomyopathy. Clin Genet. 2016;90:49\u201354.","journal-title":"Clin Genet"},{"key":"3613_CR15","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1056\/NEJMoa1110186","volume":"366","author":"DS Herman","year":"2012","unstructured":"Herman DS, Lam L, Taylor MRG, Wang L, Teekakirikul P, Christodoulou D, et al. Truncations of titin causing dilated cardiomyopathy. N Engl J Med. 2012;366:619\u201328.","journal-title":"N Engl J Med"},{"key":"3613_CR16","doi-asserted-by":"publisher","unstructured":"Roberts AM, Ware JS, Herman DS, Schafer S, Baksi J, Bick AG et al. Integrated allelic, transcriptional, and phenomic dissection of the cardiac effects of titin truncations in health and disease. Sci Transl Med. 2015 [cited 2024 Jun 17];7. Available from: https:\/\/doi.org\/10.1126\/scitranslmed.3010134","DOI":"10.1126\/scitranslmed.3010134"},{"key":"3613_CR17","doi-asserted-by":"publisher","first-page":"5313","DOI":"10.1038\/s41598-024-56154-7","volume":"14","author":"AG Jolfayi","year":"2024","unstructured":"Jolfayi AG, Kohansal E, Ghasemi S, Naderi N, Hesami M, MozafaryBazargany M, et al. Exploring TTN variants as genetic insights into cardiomyopathy pathogenesis and potential emerging clues to molecular mechanisms in cardiomyopathies. Sci Rep. 2024;14:5313.","journal-title":"Sci Rep"},{"key":"3613_CR18","doi-asserted-by":"publisher","first-page":"e002480","DOI":"10.1161\/CIRCGEN.119.002480","volume":"13","author":"A Morales","year":"2020","unstructured":"Morales A, Kinnamon DD, Jordan E, Platt J, Vatta M, Dorschner MO, et al. Variant interpretation for dilated cardiomyopathy: refinement of the American college of medical genetics and genomics\/clingen guidelines for the DCM precision medicine study. Circ Genom Precis Med. 2020;13:e002480.","journal-title":"Circ Genom Precis Med"},{"key":"3613_CR19","first-page":"1102","volume":"18","author":"A Maver","year":"2016","unstructured":"Maver A, Lovrecic L, Volk M, Rudolf G, Writzl K, Blatnik A, et al. Phenotype-driven gene target definition in clinical genome-wide sequencing data interpretation. Genet Sci. 2016;18:1102\u201310.","journal-title":"Genet Sci"},{"key":"3613_CR20","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/gim.2017.142","volume":"20","author":"G Bergant","year":"2018","unstructured":"Bergant G, Maver A, Lovrecic L, \u010cuturilo G, Hodzic A, Peterlin B. Comprehensive use of extended exome analysis improves diagnostic yield in rare disease: a retrospective survey in 1,059 cases. Genet Med. 2018;20:303\u201312.","journal-title":"Genet Med"},{"key":"3613_CR21","first-page":"405","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet Sci. 2015;17:405\u201324.","journal-title":"Genet Sci"},{"key":"3613_CR22","unstructured":"Durkie M, Cassidy E-J, Berry I, Owens M, Turnbull C, Taylor RW et al. ACGS best practice guidelines for variant classification in rare disease. 2024."},{"key":"3613_CR23","first-page":"205","volume":"11","author":"G Bergant","year":"2021","unstructured":"Bergant G, Maver A, Peterlin B. Whole-genome sequencing in diagnostics of selected Slovenian undiagnosed patients with rare disorders. Life (Basel). 2021;11:205.","journal-title":"Life (Basel)"},{"key":"3613_CR24","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1093\/bioinformatics\/btr330","volume":"27","author":"P Danecek","year":"2011","unstructured":"Danecek P, Auton A, Abecasis G, Albers CA, Banks E, DePristo MA, et al. The variant call format and vcftools. Bioinformatics. 2011;27:2156\u20138.","journal-title":"Bioinformatics"},{"key":"3613_CR25","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1086\/519795","volume":"81","author":"S Purcell","year":"2007","unstructured":"Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81:559\u201375.","journal-title":"Am J Hum Genet"},{"key":"3613_CR26","unstructured":"Microsoft Corporation. Microsoft Excel. Available from: https:\/\/www.microsoft.com\/sl-si\/microsoft-365\/excel?legRedir=true&CorrelationId=b643d8c1-1038-42ab-a5db-36aa34fb9415"},{"key":"3613_CR27","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nbt.1754","volume":"29","author":"JT Robinson","year":"2011","unstructured":"Robinson JT, Thorvaldsd\u00f3ttir H, Winckler W, Guttman M, Lander ES, Getz G, et al. Integrative genomics viewer. Nat Biotechnol. 2011;29:24\u20136.","journal-title":"Nat Biotechnol"},{"key":"3613_CR28","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1093\/bioinformatics\/bth457","volume":"21","author":"JC Barrett","year":"2005","unstructured":"Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21:263\u20135.","journal-title":"Bioinformatics"},{"key":"3613_CR29","doi-asserted-by":"publisher","first-page":"D933","DOI":"10.1093\/nar\/gkac958","volume":"51","author":"FJ Martin","year":"2023","unstructured":"Martin FJ, Amode MR, Aneja A, Austine-Orimoloye O, Azov AG, Barnes I, et al. Ensembl 2023. Nucleic Acids Res. 2023;51:D933\u201341.","journal-title":"Nucleic Acids Res"},{"key":"3613_CR30","doi-asserted-by":"publisher","first-page":"D1188","DOI":"10.1093\/nar\/gkac1072","volume":"51","author":"LR Nassar","year":"2023","unstructured":"Nassar LR, Barber GP, Benet-Pag\u00e8s A, Casper J, Clawson H, Diekhans M, et al. The UCSC genome browser database: 2023 update. Nucleic Acids Res. 2023;51:D1188\u201395.","journal-title":"Nucleic Acids Res"},{"key":"3613_CR31","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1002\/humu.23626","volume":"39","author":"AN Abou Tayoun","year":"2018","unstructured":"Abou Tayoun AN, Pesaran T, DiStefano MT, Oza A, Rehm HL, Biesecker LG, et al. Recommendations for interpreting the loss of function PVS1 ACMG\/AMP variant criterion. Hum Mutat. 2018;39:1517\u201324.","journal-title":"Hum Mutat"},{"key":"3613_CR32","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.1093\/cvr\/cvab328","volume":"118","author":"CM Loescher","year":"2022","unstructured":"Loescher CM, Hobbach AJ, Linke WA. Titin (TTN): from molecule to modifications, mechanics, and medical significance. Cardiovascular Res. 2022;118:2903\u201318.","journal-title":"Cardiovascular Res"},{"key":"3613_CR33","first-page":"242","volume":"178","author":"S Van Heesch","year":"2019","unstructured":"Van Heesch S, Witte F, Schneider-Lunitz V, Schulz JF, Adami E, Faber AB, et al. The translational landscape of the human heart. Cell. 2019;178:242\u2013e26029.","journal-title":"Translational Landsc Hum Heart Cell"},{"key":"3613_CR34","doi-asserted-by":"publisher","first-page":"eabd7287","DOI":"10.1126\/scitranslmed.abd7287","volume":"13","author":"Q McAfee","year":"2021","unstructured":"McAfee Q, Chen CY, Yang Y, Caporizzo MA, Morley M, Babu A, et al. Truncated titin proteins in dilated cardiomyopathy. Sci Transl Med. 2021;13:eabd7287.","journal-title":"Sci Transl Med"},{"key":"3613_CR35","doi-asserted-by":"publisher","first-page":"e169753","DOI":"10.1172\/JCI169753","volume":"134","author":"D Kellermayer","year":"2024","unstructured":"Kellermayer D, Tordai H, Kiss B, T\u00f6r\u00f6k G, P\u00e9ter DM, Sayour AA, et al. Truncated titin is structurally integrated into the human dilated cardiomyopathic sarcomere. J Clin Invest. 2024;134:e169753.","journal-title":"J Clin Invest"},{"key":"3613_CR36","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/ejhf.673","volume":"19","author":"JA Jansweijer","year":"2017","unstructured":"Jansweijer JA, Nieuwhof K, Russo F, Hoorntje ET, Jongbloed JDH, Lekanne Deprez RH, et al. Truncating titin mutations are associated with a mild and treatable form of dilated cardiomyopathy. Eur J Heart Fail. 2017;19:512\u201321.","journal-title":"Eur J Heart Fail"},{"key":"3613_CR37","first-page":"192","volume":"19","author":"R Walsh","year":"2017","unstructured":"Walsh R, Thomson KL, Ware JS, Funke BH, Woodley J, McGuire KJ, et al. Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples. Genet Sci. 2017;19:192\u2013203.","journal-title":"Genet Sci"},{"key":"3613_CR38","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1016\/j.jacc.2019.06.072","volume":"74","author":"M Gigli","year":"2019","unstructured":"Gigli M, Merlo M, Graw SL, Barbati G, Rowland TJ, Slavov DB, et al. Genetic risk of arrhythmic phenotypes in patients with dilated cardiomyopathy. J Am Coll Cardiol. 2019;74:1480\u201390.","journal-title":"J Am Coll Cardiol"},{"key":"3613_CR39","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1038\/s41436-020-01049-x","volume":"23","author":"F Mazzarotto","year":"2021","unstructured":"Mazzarotto F, Hawley MH, Beltrami M, Beekman L, de Marvao A, McGurk KA, et al. Systematic large-scale assessment of the genetic architecture of left ventricular noncompaction reveals diverse etiologies. Genet Med. 2021;23:856\u201364.","journal-title":"Genet Med"},{"key":"3613_CR40","doi-asserted-by":"publisher","first-page":"3444","DOI":"10.1073\/pnas.0608543104","volume":"104","author":"MH Radke","year":"2007","unstructured":"Radke MH, Peng J, Wu Y, McNabb M, Nelson OL, Granzier H, et al. Targeted deletion of titin N2B region leads to diastolic dysfunction and cardiac atrophy. Proc Natl Acad Sci USA. 2007;104:3444\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3613_CR41","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/ng816","volume":"30","author":"X Xu","year":"2002","unstructured":"Xu X, Meiler SE, Zhong TP, Mohideen M, Crossley DA, Burggren WW, et al. Cardiomyopathy in zebrafish due to mutation in an alternatively spliced exon of titin. Nat Genet. 2002;30:205\u20139.","journal-title":"Nat Genet"},{"key":"3613_CR42","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.yjmcc.2010.05.006","volume":"49","author":"E-J Lee","year":"2010","unstructured":"Lee E-J, Peng J, Radke M, Gotthardt M, Granzier HL. Calcium sensitivity and the Frank-Starling mechanism of the heart are increased in titin N2B region-deficient mice. J Mol Cell Cardiol. 2010;49:449\u201358.","journal-title":"J Mol Cell Cardiol"},{"key":"3613_CR43","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/j.bpj.2011.06.054","volume":"101","author":"J Nedrud","year":"2011","unstructured":"Nedrud J, Labeit S, Gotthardt M, Granzier H. Mechanics on myocardium deficient in the N2B region of titin: the cardiac-unique spring element improves efficiency of the cardiac cycle. Biophys J. 2011;101:1385\u201392.","journal-title":"Biophys J"},{"key":"3613_CR44","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.abb.2012.12.004","volume":"535","author":"E-J Lee","year":"2013","unstructured":"Lee E-J, Nedrud J, Schemmel P, Gotthardt M, Irving TC, Granzier HL. Calcium sensitivity and myofilament lattice structure in titin N2B KO mice. Arch Biochem Biophys. 2013;535:76\u201383.","journal-title":"Arch Biochem Biophys"},{"key":"3613_CR45","doi-asserted-by":"publisher","first-page":"e175501","DOI":"10.1172\/jci.insight.175501","volume":"9","author":"P Zhu","year":"2024","unstructured":"Zhu P, Li J, Yan F, Islam S, Lin X, Xu X. Allelic heterogeneity of TTNtv dilated cardiomyopathy can be modeled in adult zebrafish. JCI Insight. 2024;9:e175501.","journal-title":"JCI Insight"},{"key":"3613_CR46","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1136\/jmedgenet-2020-107178","volume":"58","author":"CR Vissing","year":"2021","unstructured":"Vissing CR, Rasmussen TB, Dybro AM, Olesen MS, Pedersen LN, Jensen M, et al. Dilated cardiomyopathy caused by truncating titin variants: long-term outcomes, arrhythmias, response to treatment and sex differences. J Med Genet. 2021;58:832\u201341.","journal-title":"J Med Genet"},{"key":"3613_CR47","doi-asserted-by":"publisher","first-page":"16409","DOI":"10.1038\/s41598-019-52911-1","volume":"9","author":"E Zaklyazminskaya","year":"2019","unstructured":"Zaklyazminskaya E, Mikhailov V, Bukaeva A, Kotlukova N, Povolotskaya I, Kaimonov V, et al. Low mutation rate in the TTN gene in paediatric patients with dilated cardiomyopathy - a pilot study. Sci Rep. 2019;9:16409.","journal-title":"Sci Rep"},{"key":"3613_CR48","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1016\/j.jacc.2017.08.063","volume":"70","author":"U Tayal","year":"2017","unstructured":"Tayal U, Newsome S, Buchan R, Whiffin N, Halliday B, Lota A, et al. Phenotype and clinical outcomes of titin cardiomyopathy. J Am Coll Cardiol. 2017;70:2264\u201374.","journal-title":"J Am Coll Cardiol"},{"key":"3613_CR49","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1038\/s41431-023-01357-1","volume":"31","author":"J Jacobs","year":"2023","unstructured":"Jacobs J, Van Aelst L, Breckpot J, Corveleyn A, Kuiperi C, Dupont M, et al. Tools to differentiate between filamin C and titin truncating variant carriers: value of MRI. Eur J Hum Genet. 2023;31:1323\u201332.","journal-title":"Eur J Hum Genet"},{"key":"3613_CR50","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1093\/eurheartj\/ehx808","volume":"39","author":"JAJ Verdonschot","year":"2018","unstructured":"Verdonschot JAJ, Hazebroek MR, Derks KWJ, Barandiar\u00e1n Aizpurua A, Merken JJ, Wang P, et al. Titin cardiomyopathy leads to altered mitochondrial energetics, increased fibrosis and long-term life-threatening arrhythmias. Eur Heart J. 2018;39:864\u201373.","journal-title":"Eur Heart J"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03613-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-03613-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03613-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T13:54:31Z","timestamp":1740750871000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-03613-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,28]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3613"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-03613-7","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,28]]},"assertion":[{"value":"5 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study adhered to the Declaration of Helsinki and was approved by the National Medical Ethics Committee of Slovenia (Approval No. 0120\u2009\u2212\u200971\/2022\/3, dated 28\/03\/2022). Written informed consent to use the data for research purposes was obtained from all study participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests. Sponsors had no role in study design, execution, interpretation, or writing.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"92"}}